Hangzhou Jiuyuan Gene Engineering

Semaglutide Patent Expired in China—But Generic Approvals Are Stuck in Regulatory Limbo

China FinanceHangzhou Jiuyuan Gene Engineering, Livzon Pharmaceutical Group, Patents, Pharmaceuticals, The United Laboratories

April 27, 2026